Literature DB >> 9110365

Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.

N M Woolhouse1, M M Qureshi, S M Bastaki, M Patel, Y Abdulrazzaq, R A Bayoumi.   

Abstract

Polymorphic N-acetyltransferase (NAT2) genotypes were determined in 106 unrelated Emiratis by PCR-RFLP analysis to obtain estimates of allele frequencies. Thirteen different genotypes were found, four associated with the rapid acetylator phenotype and nine with the slow acetylator phenotype. Among 67 phenotypically slow acetylators, there was 100% concordance between phenotype and genotype. Among 39 phenotypically rapid acetylators, 37 possessed at least one wild type allele; a 95% concordance with genotype. Seven different NAT2 alleles associated with slow acetylation were found. The commonest was a NAT2*5 type (C481T) allele which occurred with a frequency of 0.53, a significantly higher frequency than has been reported for other ethnic groups. A second slow allele, a NAT2*6 type (G590A), occurred with a frequency of 0.21. The most common genotypes found were NAT2*5/*5 homozygotes, NAT2*5/*6 heterozygotes and NAT2*4/*5 heterozygotes with frequencies of 0.25, 0.25 and 0.22 respectively. The high overall prevalence of alleles associated with slow acetylation (173/212; 81.6%) among Emiratis is consistent with previously reported high frequency of the slow acetylator phenotype in Arabs. Two apparently new slow alleles were identified but have not yet been fully characterized. One appears to be a NAT2*5 variant allele. The other uncharacterized allele appears likely to contain an entirely new mutation associated with slow acetylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9110365     DOI: 10.1097/00008571-199702000-00010

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  18 in total

1.  Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Authors:  Etienne Patin; Luis B Barreiro; Pardis C Sabeti; Frédéric Austerlitz; Francesca Luca; Antti Sajantila; Doron M Behar; Ornella Semino; Anavaj Sakuntabhai; Nicole Guiso; Brigitte Gicquel; Ken McElreavey; Rosalind M Harding; Evelyne Heyer; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2006-01-13       Impact factor: 11.025

2.  Acetylation pharmacogenetics and renal function in diabetes mellitus patients.

Authors:  S O Banjoko; K S Akinlade
Journal:  Indian J Clin Biochem       Date:  2010-08-25

3.  Distribution of arylamine N-acetyltransferase 2 (nat2) genotypes among Omanis.

Authors:  Musbah O M Tanira; Mehmet Simsek; Khalid Al Balushi; Khulood Al Lawatia; Hameedah Al Barawani; Riad A Bayoumi
Journal:  J Sci Res Med Sci       Date:  2003-08

4.  Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.

Authors:  Valery V Bakayev; Forozan Mohammadi; Moslem Bahadori; Mariam Sheikholslami; Arash Javeri; Mohammad R Masjedi; Ali A Velayati
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

5.  Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.

Authors:  Rika Yuliwulandari; Qomariyah Sachrowardi; Nao Nishida; Miwa Takasu; Lilian Batubara; Tri Panjiasih Susmiarsih; Jecti Teguh Rochani; Riyani Wikaningrum; Risa Miyashita; Taku Miyagawa; Abdul Salam Mudzakir Sofro; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

Review 6.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 7.  Genotype-Guided Hydralazine Therapy.

Authors:  Kimberly S Collins; Anthony L J Raviele; Amanda L Elchynski; Alexander M Woodcock; Yang Zhao; Rhonda M Cooper-DeHoff; Michael T Eadon
Journal:  Am J Nephrol       Date:  2020-09-14       Impact factor: 3.754

8.  NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations.

Authors:  Mansour S Al-Moundhri; Mohamed Al-Kindi; Maryam Al-Nabhani; Bassim Al-Bahrani; Ikram A Burney; Ali Al-Madhani; Shyam S Ganguly; Misbah Tanira
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

9.  Arylamine N-acetyltransferase-2 genotypes in the Thai population.

Authors:  Veerapol Kukongviriyapan; Auemduan Prawan; Wichittra Tassaneyakul; Jareerat Aiemsa-Ard; Benjamart Warasiha
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

10.  Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer.

Authors:  Amjad Mahasneh; Amal Jubaili; Ahmed El Bateiha; Mohammad Al-Ghazo; Ismail Matalka; Mousa Malkawi
Journal:  Genet Mol Biol       Date:  2012-11-09       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.